EcoDrugPlus

Aurora Kinase B-Like

Ensembl ID : ENSSPAG00000002883
Gene Symbol: LOC103367279
3 Cross references
205 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSSPAG00000008929
Gene Symbol: LOC103355696
3 Cross references
195 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSSPAG00000018286
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSPAG00000017878
Gene Symbol: BDKRB2
1 Cross references
146 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSPAG00000017919
Gene Symbol: BDKRB2
1 Cross references
243 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSPAG00000017834
Gene Symbol: BDKRB2
4 Cross references
167 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSPAG00000015326
Gene Symbol: BDKRB2
1 Cross references
239 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b-Like

Ensembl ID : ENSSPAG00000013640
Gene Symbol: LOC103374853
3 Cross references
193 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1f Subunit

Ensembl ID : ENSSPAG00000007117
Gene Symbol: CACNA1FB
1 Cross references
176 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 8a

Ensembl ID : ENSSPAG00000014263
Gene Symbol: CACNG8A
1 Cross references
167 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSSPAG00000002702
Gene Symbol: CASR
3 Cross references
202 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSSPAG00000014754
Gene Symbol: CACNA2D1
3 Cross references
226 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).